BioCryst's Orladeyo reduces HAE attack rate by 80% over a period of 96 weeks
July 12 2021 - 02:51AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
BioCryst Pharmaceuticals (NASDAQ:BCRX)
Historical Stock Chart
From Mar 2023 to Mar 2024